Tale of Three Companies (DPC, Bayer, Dade)
Posted by ~Ray @ 2007-11-27 20:38:22
Many of who I spoke to at Siemens LAX did not seem surprised. We've been through it and evaluate that JRA would chose his populate over former Bayer/DPC management. I haven't read the announcement in detail but my gut knee-jerk reaction is this. The organization seems to go DB's current organization (if any DB populate get a hold of the org map please comment). Next only 50% of the upper management cater is DB populate. However. DB people are placed in key position to make a difference in the new company. Another interesting thing. JB (formerly R&D) is now in charge of Business Development. ordain this convey he's gone from LA?For me. I'm keeping my options open (resume updated and posted) doing my job well and waiting for judgement. Might as well not destroy bridges high tech business is a small world. Good luck Siemens LAX populate.
Siemens Medical Solutions Diagnostics (DX)Organizational AnnouncementTo: All Siemens Medical Solutions Diagnostics EmployeesAll Dade Behring Employees From: Erich R. Reinhardt. President and CEO. Siemens Medical SolutionsJim Reid-Anderson. head. President and CEO. Dade BehringDate: September 11. 2007affect: Executive Leadership Organizational Announcement affix Dade Behring Transaction ClosingWe are pleased to inform the new organizational coordinate and the Executive Leadership Team (ELT) of Siemens Medical Solutions Diagnostics (DX) that will change state effective upon the closing of Siemens’ acquisition of Dade Behring. This newly named ELT leverages talent from both the Siemens Medical Solutions and Dade Behring organizations and brings together a strong leadership aggroup that ordain control our customer excellence strategy forward taking the new organization to the next level. Identifying the key functional leaders early on ordain enable them to set clear direction regarding the integration affect and related activities and will allow us to more quickly and efficiently combine our businesses once the transaction is closed. Additionally identifying the key leaders establishes clear lines of accountability and streamlines communications for our customers and our employees. EXECUTIVE LEADERSHIP TEAM AND ORGANIZATIONAL STRUCTUREThe ELT of Siemens Medical Solutions Diagnostics (DX) in addition to Jim will be as follows:go Balk. Joe Bernardo. John Blackwood. Randy Daniel. John Duffey. Dave Edelstein. David Hickey. Mike Johnson. Arnd Kaldowski. Kathy Kennedy. Nancy Krejsa. David Okrongly. Donal Quinn. Jochen Schmitz and Mark Wolsey-PaigeIn addition to announcing the future ELT of DX decisions undergo also been made regarding several other leadership positions. We felt it was allot to give greater clarity as soon as possible around geographic and product line leadership within the customer-facing organization. Although we are not naming all of the direct reports to the ELT at this time we wanted to communicate decisions as they are made. The following individuals will anticipate their respective roles upon the closing of the transaction between Siemens Medical Solutions and Dade Behring:Jochen Schmitz. Chief Financial Officer for Siemens Medical Solutions Diagnostics since January. 2007 ordain act in this role in the newly consolidated organization and ordain be appointed Executive Vice President for Siemens Medical Solutions Diagnostics. Jochen ordain inform to Klaus Stegemann. Chief Financial Officer. Siemens Medical Solutions with a dotted line to Jim. Jochen joined Siemens in 1996 in the area of Corporate Finance and he has held several positions of increasing responsibility within the finance function. In 2004 he joined the Medical Solutions Group as continue of Performance Controlling and was then promoted to Chief Financial Officer of the Molecular Imaging Division in 2005. John Duffey currently Chief Financial Officer for Dade Behring ordain assume a new lay as the Chief Integration command reporting directly to Jim and will be responsible for all aspects of the integration process including the overall management and coordination of integration activities across functions monitoring of financial targets associated with the integration supporting the leadership aggroup with the implementation of the new organization and leveraging the communications aggroup to facilitate effective information sharing across the organization. John has had a series of senior financial roles with Dade Behring and previously worked for determine Waterhouse. John ordain work closely with Jochen over the coming months to verify a smooth and successful transition of Dade Behring’s pay answer. Dean Simcoe who is currently Integration Manager for Siemens Medical Solutions Diagnostics will transition his responsibilities to John and longer call Dean ordain act into another role in the company once the Dade Behring integration is fully underway.·Mark Grossi currently Senior Vice President. Global Service and give for Siemens Medical Solutions Diagnostics ordain connect the integration aggroup reporting to John Duffey and will compete a significant role in helping to integrate the operations of the two companies. Arnd Kaldowski currently Senior Vice President for the inform of compassionate business for Siemens Medical Solutions Diagnostics ordain continue in his current position in the newly consolidated organization and will report directly to Jim. From 2003 until 2006. Arnd worked in the Ultrasound Division of Siemens Medical Solutions where he led the Premium Performance Product lie as a command Manager. He later took over Global Sales and Marketing for the entire division. Prior to joining Siemens he worked for a Venture Capital firm where he was an Investment Director involved in start-ups and was the co-founder of a software start-up company. Arnd started his career working for Boston Consulting assort. David Okrongly currently Senior Vice President. Molecular business for Siemens Medical Solutions Diagnostics ordain be in his current position in the newly consolidated organization and act to be responsible for Molecular strategy and business planning strategic marketing product management business development and program management for all existing and new molecular products as well as molecular reagent R&D. David ordain report directly to Jim. The molecular business will also continue to be responsible for developing aligned strategies and molecular product offerings with the in-vivo business of Siemens. David joined Bayer Diagnostics in 1997 as Vice President. R&D Hematology and was later named Vice President. Methods Development and Senior Vice President. R&D for the Laboratory Testing Segment. In 2004. David was named Senior Vice President. Global investigate & Development for Bayer Healthcare’s Diagnostics Division and assumed his current role in January 2007. Sidney Aroesty currently Chief Operating Officer for Siemens Medical Solutions Diagnostics ordain act in his current role until the transaction closes and be actively involved in the integration planning affect. Donal Quinn currently Chief Operating Officer at Dade Behring will be appointed Executive Vice President and Chief Customer Officer of Siemens Medical Solutions Diagnostics where he ordain be responsible for Global Sales and Service. Global Marketing. Marketing Services. Market Analysis and Global Logistics and ordain report directly to Jim. Prior to his current role. Donal was President. Global Customer Management for Dade Behring. Before joining Dade Behring. Donal worked as Global.[ADVERTHERE]Related article:
http://www.biofind.com/Rumor/Default.aspx?ID=117811
0 Comments:
No comments have been posted yet!
|
